Revenue: As of FY2025 Q1, the actual value is USD 259.9 M, missing the estimate of USD 266.11 M.EPS: As of FY2025 Q1, the actual value is USD 0.35.EBIT: As of FY2025 Q1, the actual value is USD 25.8 M.<h3>Home Health Segment</h3><ul><li>Net Service Revenue: $200.6 million for Q1 2025, a decrease from $213.2 million in Q1 2024, representing a 5.9% decline.</li><li>Cost of Service: $103.4 million for Q1 2025, down from $109.9 million in Q1 2024, a 5.9% decrease.</li><li>Segment Adjusted EBITDA: $38.3 million for Q1 2025, down from $43.2 million in Q1 2024, an 11.3% decrease.</li><li>Operational Metrics: Average daily census decreased by 2.4% to 41,236, and visits per episode decreased by 6.7% to 13.9.</li></ul><h3>Hospice Segment</h3><ul><li>Net Service Revenue: $59.3 million for Q1 2025, an increase from $49.2 million in Q1 2024, representing a 20.5% increase.</li><li>Cost of Service: $26.8 million for Q1 2025, up from $24.3 million in Q1 2024, a 10.3% increase.</li><li>Segment Adjusted EBITDA: $15.0 million for Q1 2025, up from $9.1 million in Q1 2024, a 64.8% increase.</li><li>Operational Metrics: Average daily census increased by 12.3% to 3,809, and revenue per patient day increased by 8.4% to $173.0.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $17.9 million for Q1 2025, compared to $17.3 million in Q1 2024.</li><li>Net Cash Provided by Investing Activities: $20.8 million for Q1 2025, primarily from the sale of an investment.</li><li>Net Cash Used in Financing Activities: -$28.2 million for Q1 2025, primarily due to debt repayments.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to exit the Covenant Adjustment Period earlier than anticipated, which will allow for improved pricing under the Credit Agreement and operational flexibility, including the pursuit of acquisitions.</li><li>Branch Closures: Four Home Health and three Hospice branches have been closed or consolidated, with four additional closures expected by the end of Q2 2025.</li><li>Pricing and Reimbursement: The proposed 2026 Hospice Rule suggests a 2.4% increase in payments, effective October 1, 2025.</li></ul>

Enhabit Home Health & Hospice | 10-Q: FY2025 Q1 Revenue Misses Estimate at USD 259.9 M